Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | Call-off from a framework agreement |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £310,000 |
| Release Date: | 29 July 2025 |
| Application Deadline: | 31 March 2025 |
| Contract Start Date: | 31 March 2025 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £310,000 |
| Award decision date: | 13 July 2025 |
| Award status: | Active |
A call off under National Microbiology Framework for the EONIS Q Assay methodology as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot (NBS) in-service evaluation for Severe Combined Immuno-Deficiency (SCID) in Screening laboratories to Revvity.
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
31 March 2025
Closed
Estimated Value
£310,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 30 September 2025 |
| Contract Duration: | 6 months |
| Procurement ID (OCID): | ocds-b5fd17-3de3e604-4e30-4129-8669-cd77fa40f9b7 |
| Notice Reference: | 7ee11c14-1da6-4e37-8db5-2c7b418c9f1d-856553 |